Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Total Debt (2019 - 2025)

Historic Total Debt for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $967406.0.

  • Bioadaptives' Total Debt fell 593.98% to $967406.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $967406.0, marking a year-over-year decrease of 593.98%. This contributed to the annual value of $1.1 million for FY2024, which is 770.83% up from last year.
  • According to the latest figures from Q3 2025, Bioadaptives' Total Debt is $967406.0, which was down 593.98% from $860636.0 recorded in Q2 2025.
  • In the past 5 years, Bioadaptives' Total Debt registered a high of $1.1 million during Q2 2024, and its lowest value of $557042.0 during Q4 2021.
  • Its 5-year average for Total Debt is $860753.3, with a median of $874737.0 in 2023.
  • Examining YoY changes over the last 5 years, Bioadaptives' Total Debt showed a top increase of 2590504.57% in 2021 and a maximum decrease of 3265.27% in 2021.
  • Over the past 5 years, Bioadaptives' Total Debt (Quarter) stood at $557042.0 in 2021, then grew by 23.3% to $686856.0 in 2022, then soared by 42.37% to $977872.0 in 2023, then increased by 7.71% to $1.1 million in 2024, then decreased by 8.15% to $967406.0 in 2025.
  • Its last three reported values are $967406.0 in Q3 2025, $860636.0 for Q2 2025, and $991590.0 during Q1 2025.